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Introduction
For many years, there has been a growing need for data 
management standards for the sharing and reuse of research 
data.  Public data sharing policies have been a part of 
government funded research for many years [1], and several 
organizations have recently reiterated this importance as 
technologies continue to make data more accessible [2-5]. Data 
collected and generated by investigators is often stored in an 
ad-hoc fashion, with a structure that is clear and consistent to 
the investigator and research team, but not necessarily by those 
who may be interested in its reuse.  This is especially important 
to public and private funding organizations, where data are 
the product of an investment and must continue to have value 
into the future. “Data stewardship” is a common term used to 
describe this new trend for researchers structuring their data to 
support future use.
Recently, the NIH and other public funding bodies have adopted 
the FAIR principles [6] as a general guideline for the necessary 
features needed to facilitate data sharing.  These features include 
Findability, Accessibility, Interoperability, and Reusability. In 
this paradigm, not only is it important that data be structured 
for reuse by other investigators, but also structured for machine 
and software interfaces as well.  More and more data are being 
accessed by software data mining and discovery platforms, and 
each requires consistent and standardized data structures to be 
effective at knowledge discovery. Fortunately, data structures 
designed to be machine-readable can be enhanced to support 
human readability as well.  The development and adoption of 
these new standards will be a recurring theme in the future of 
research.
In addition to making raw research data accessible, FAIR 
principles are intended to apply to the software that researchers 
use to analyze their datasets.  This has led to the concepts of 
data authorship and research objects. [7, 8] Research objects 
can include the analysis software code used to generate results 
in addition to the dataset itself. Creating these structures can 
be challenging in terms of time spent by investigators [9]. It 
is also cumbersome to make shared software analysis code 
reusable.  The efficient reuse of software source code is a focus 
of the discipline of software engineering [10], and effort must be 
invested by programmers early in the development process for 
software to be reusable. Without this effort, it takes more time to 
understand the intent of the original programmer than to write 
a new program.  Modern programming languages have made it 
easier to apply the principles of software reuse and even novice 
programmers can now develop software that is easy to extend, 
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Introduction: Data sharing in clinical research is critical for increasing knowledge discovery. Data 
and software tools should be FAIR: Findable, Accessible, Inter-operable and Re-usable. Many 
bottlenecks exist in the process of a clinical investigator using shared data including data acquisition 
and statistical analysis. The objective of this project is to develop a structure for sharing data and 
providing rapid automated statistical analysis through creation of a pre-packaged, open-source 
software container.
Methods: We use the open source software container technologies VirtualBox and Vagrant to create 
a template for sharing clinical data and analysis scripts as a single container.  We use a timer to 
record the time necessary to setup and initialize the software container and view the results.
Results: We have created a template for sharing data and analysis scripts together using open 
source software container technologies VirtualBox and Vagrant. We found the time needed to 
initialize the container to be 5 minutes and 36 seconds for a macOS-based machine and 7 minutes 
and 2 seconds for a Windows-based machine. Containers can be downloaded and executed from 
any Mac or Windows computer allowing both the reuse of and interaction with the data.  This greatly 
reduces the time and effort needed to obtain and analyze clinical data.
Conclusion: Reducing the time and effort needed to obtain and analyze clinical data increases 
the time available for data exploration and the discovery of new knowledge. This can be effectively 
achieved using software containers and virtualization.
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modify, and reuse [11]. In the area of clinical research, following 
FAIR principles continues to be a challenge. Furthermore, little 
work has been done to make it simple for clinical investigators 
to use these principles in obtaining and analyzing their data.
From informal interviews with pneumonia researchers and 
statisticians we found several obstacles to creating shared 
datasets in this field. Two obstacles stand out from the others. 
The first was the difficulty in giving the data the appropriate 
context to be interpreted accurately by subsequent investigators. 
This context can consist of the specific features of the study 
population, the conditions under which the data was collected, 
and the types of research questions the data was gathered 
to answer.  The second major obstacle is the time and effort 
needed to replicate the analysis pipeline used by the primary 
investigator.  These pipelines can be very sophisticated and their 
setup can be time consuming to replicate. If this setup could be 
automated it could improve the ability of shared data to be used 
by others.
Our objective was to improve the utility of shared datasets 
by creating a fast and easy to use software container for 
sharing research data and statistical analyses.  This container 
will support the FAIR principles of findability, accessibility, 
interoperability, and reusability. We record the startup time 
needed for the software container and describe the steps 
necessary for its setup and execution.  The container will also 
support the addition of contextual information about the data in 
the form of documentation and commentary from the creators.
Terms and Abbreviations 
OS - operating system The software for managing interactive 
programs on a computer. 
virtual machine Software that partitions physical hardware 
into virtual hardware that can run contained 
software environments. 
FAIR Findable, Accessible, Interoperable, Reusable 
data stewardship The facilitation of data re-use by researchers 
and investigators 
virtualization the process of running software inside a 
virtual machine 
VirtualBox An open source software virtualization 
program 
open source software  Software that is made freely available with 
little to no licensing restrictions 
Vagrant open source virtual machine management 
software 
R An open source programming language 
supporting many statistical tests 
Linux A popular open source operating system 
proprietary software software that has licensing restrictions 
governing its use and distribution 
Methods
Data used in this study originate from the University of 
Louisville Pneumonia Study, a three-year study on the 
incidence, epidemiology, and clinical outcomes of hospitalized 
patients with community-acquired pneumonia[12]. This study 
took place from June 1, 2014 to March 31, 2017. 
When designing the software container, we set out to address 
each of the four FAIR principles to the best of our ability.  How 
an investigator addresses FAIR principles when sharing data 
will depend upon many factors, such as the type of data being 
shared and the type of software used to analyze data.  For these 
reasons, the methods used for this study may not translate in 
their entirety to other studies.  We describe below the FAIR 
principle and how it was addressed.
1. Findability: Data should be easy to find.  For this study we 
used Zenodo[13], a free online service funded by CERN[14] 
to generate a DOI or permanent document object identifier, 
for our dataset and software container.  Zenodo registers 
DOIs through DataCite, and provides means for updating 
and retracting incorrect data[15].
2. Accessibility: Data should be easy to access. Our data is de-
identified and will be hosted online along with the software 
container.  Any user with an internet connection can access 
it.
3. Interoperability: Data should be in a standardized format. 
We share our data in a comma separated value file with a 
header row describing the variable name. This is a common 
standard for clinical data analysis.
4. Reusability: Data should be reusable.  We believe a 
software container is a viable method for addressing this 
principle, as it will quickly provide the means to explore 
shared data for secondary analyses.
To develop the software container, we use several open-
source applications. First, to pre-package an operating system 
for use on any machine, we used two open source software 
virtualization solutions: VirtualBox[16] and Vagrant[17]. 
VirtualBox is a software virtualization environment that is 
designed to manage guest operating systems running within a 
primary host operating system. It’s one of many technologies 
designed to perform this task, with other notable examples 
being Microsoft’s Hyper-V and Dell’s VMWare.  The primary 
benefit of software virtualization is the ability to quickly and 
easily replicate the operating conditions of software without 
needing to replicate their expensive hardware environment. 
This allowed us to create a virtual computer, containing data and 
automated analysis scripts in a single container that can be run 
through another computer, regardless of the operating system 
(e.g. Microsoft Windows, Apple macOS, etc.). VirtualBox is the 
most widely used open source virtualization software and is 
used in health informatics for security and performance testing, 
but is being used more and more for the packaging of data and 
analysis pipelines for reuse [18, 19]. Vagrant is a virtualization 
management software designed to simplify the organization and 
description of virtual machine environments. Vagrant facilitates 
storing a robust description of the entire software environment 
needed to perform a given task. This software makes it easier for 
investigators to open the virtual machine and visualize results 
of their analysis. This software allowed us to encapsulate the 
dataset and the analytical software needed to perform analysis.
In these environments, the dataset is stored in a comma 
separated values (.csv) file, allowing easy access by analytical 
software. This standard file format is also readable into any 
spreadsheet program and requires minimal electronic storage 
space. This was desirable to limit the processing and memory 
overhead required by the virtual machine, allowing for more 
processing power to be devoted to the analysis engine.
Statistical analysis scripts were written in the R environment 
[20]. This is an open-source software commonly used for 
highlevel statistical analysis. Common analyses used by clinical 
investigators were re-created in this programming environment 
and packaged along with R version 3.3.2 and the clinical data 
inside of the virtual machine.
In the case of data sharing, the data and analysis scripts are 
stored in a folder along with a virtual machine description. 
When the machine is initiated using Vagrant, the dataset and 
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analysis scripts are loaded into the guest environment and the 
virtual machine is ready to perform the analysis and display 










Fig. 1. Diagram of the data object template.  Included with the data is the 
Object Description File, containing the configuration information needed 
to replicate the analysis environment, including the statistical software 
(R) and analysis source code.
The steps necessary to open the virtual machine and perform 
analysis are summarized as follows:
1. Ensure that Vagrant and VirtualBox are downloaded and 
installed on the local machine.
2. Download the Data Container and unzip into a directory (e.g. 
Computer desktop).
3. Double click on the startup file in the directory corresponding 
to your operating system (Microsoft Windows or Apple 
macOS).
The virtual machine initializes its startup sequence before 
loading the statistical programming environment and executing 
the packaged analysis script. At this point a user familiar with 
the R analysis software can explore the automatically loaded 
dataset and perform analysis.  
This process was tested using the University of Louisville 
Pneumonia Study lactic acid dataset.  The lactate study featured 
3658 patients enrolled from June 1, 2014 to May 31, 2016. 
Lactate levels were associated with higher in-hospital mortality, 
with patients having ≥4 mmol/L of lactic acid having a nearly 
a 3-fold increase in odds of dying during hospitalization. The 
dataset is available for download[21]. The analysis scripts 
performed for this study included:
 
1. aggregate descriptive analyses (frequency with percent for 
categorical variables and mean with standard deviation for 
continuous variables),
2. bivariable comparisons of patient characteristics between 
those with and without lactate levels of ≥4 mmol/L using 
student’s t-tests for continuous variables and Chi-squared 
tests for categorical variables, 
3. univariable logistic regression for calculation of unadjusted 
odds ratios, and 
4. multivariable logistic regression for calculation of adjusted 
odds ratios comparing the adjusted odds of in-hospital 
mortality for those with and without lactate levels of ≥4 
mmol/L. 
The variable names and descriptions are shown in Table 1. 
We record the time needed to display analysis results for this 
dataset on two different host platforms: Microsoft Windows and 
Apple macOS.
Table 1. Variable names and descriptions.
Variable Description Coding 
age Categorized Age in Years  
sex Sex 1=Male 0=Female 
nursinghome Nursing Home Resident 1=Yes 0=No 
neoplastic History of Neoplastic Disease (past year) 1=Yes 0=No 
liver History of Liver Disease 1=Yes 0=No 
chf History of Congestive Heart Failure 1=Yes 0=No 
cvd History of Cerebrovascular Disease 1=Yes 0=No 
renal History of Renal Disease 1=Yes 0=No 
mental Altered Mental Status on admission 1=Yes 0=No 
hr125 Heart Rate > 125 beats/minute 1=Yes 0=No 
rr30 Respiratory Rate >30 breaths/minute 1=Yes 0=No 
sbp90 Systolic Blood Pressure < 90 mmHg 1=Yes 0=No 
templow Temperature <35 degrees C 1=Yes 0=No 
temphigh Temperature >= 40 degrees C 1=Yes 0=No 
ph735 Arterial pH <7.35 1=Yes 0=No 
bun30 Blood Urea Nitrogen >=30 mg/dl 1=Yes 0=No 
na130 Sodium <130 mmol/L 1=Yes 0=No 
gluc250 Glucose >=250 mg/dl 1=Yes 0=No 
hematocrit30 Hematocrit < 30% 1=Yes 0=No 
pao260 Partial pressure of arterial O2 <60 mmHg 1=Yes 0=No 
peffusion Pleural effusion present 1=Yes 0=No 
copd History of COPD 1=Yes 0=No 
diabetes History of Diabetes 1=Yes 0=No 
icudirect Patient admitted directly to ICU 1=Yes 0=No 
imv Invasive mechanical ventilation on day 0 1=Yes 0=No 
vaso Vasopressors taken on day 0 1=Yes 0=No 
psi4or5 Pneumonia Severity Risk Class IV or V 1=Yes 0=No 
curb4or5 CURB-65 score 4 or 5 1=Yes 0=No 
lactate Lactate level 
0= <2 mmol/L 
1= 2-4 mmol/L 
2= ≥4 mmol/L 
ihm In-hospital mortality 1=Yes 0=No 
clinical_failure Clinical Failure within two weeks of admission 1=Yes 0=No 
los Length of Stay (in days)  
los_yn Patient discharged within 2 weeks 1=Yes 0=No 
tcs Time to clinical stability (in days)  
tcs_yn Patient clinically stable within 1 week 1=Yes 0=No 
Results
Host machine specifications and display times are shown in 
Table 2.  The first startup time includes the time needed to 
download the initial virtual machine operating system, which 
will vary depending on many factors such as connection speed 
and network congestion.  If the user shuts down the virtual 
machine after interacting with data, subsequent changes to the 
system will be much faster as shown in the subsequent startup 
time column. The large time difference in the two compared 
operating systems is due to the solid-state storage technology 
used in all new Apple computers, and not available in the 
Windows Server used in this study.  A Windows system with 
solid state technology would have comparable startup times to 
the Apple system.
Table 2. Startup times for the software container on macOS and 
Windows platforms
Machine First Startup Time Subsequent Startup Times 
Apple macOS MacBook Pro:  
2Ghz i5 dual core 
16GB Memory 
5m:36s 0m:31s 
Microsoft Windows Server 2012  
Dell PowerEdge 610: 
2.5Ghz i5 quad core 
96GB Memory 
7m:02s 2m:56s 
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The process of the virtual machine after downloading and 
installing is as follows, assuming the free Vagrant and VirtualBox 
software have also already been installed. First, the system will 
download a free Linux environment called Ubuntu [22]. After 
this has been downloaded, the virtual machine boots and starts 
downloading the current R software needed to perform analysis. 
Because R includes many different libraries needed to perform 
various analyses, this typically requires 2-3 minutes. Once the 
installation and configuration of R is complete, the user will be 
in the R command line environment and the system will have 
executed the output of the packaged study analysis. The results 
of the analysis is shown in Figures 2 and 3.
Fig. 2. Screenshot of the generated patient characteristics table for the 
University of Louisville Pneumonia Study Lactic Acid dataset.
Fig. 3. A screenshot of the univariable and multivariable logistic 
regression output of the virtual machine.
Discussion
To our knowledge, this study was the first of its kind to create a 
pre-packaged software container for data sharing and automated 
statistical analysis of clinical research data. The open-source 
software used makes the container free and readily usable by all 
individuals with a computer and internet access.  The container 
opens and installs rapidly, and provides automated output for 
results.
We believe that including the statistical software environment 
used to produce the results for a study dataset is an important 
contribution to data sharing and data authorship. We have 
developed a template for this type of data sharing for which the 
setup time needed to see and interact with results is negligible. 
Providing the details of an analysis exactly as they were 
performed is valuable to original study investigators and those 
wanting to perform secondary analyses. 
The nature of data sharing is constantly changing and the most 
effective requirements are still an item of debate [23-27]. It is 
generally agreed that data sharing plans are beneficial to all 
research stakeholders, but the most cost-effective way to achieve 
data sharing is still unclear.  The argument is often made that 
the only way to overcome the cost obstacles of data sharing 
requirements is to take advantage of a highly-centralized 
system with robust and standardized requirements for data and 
metadata. Systems like these are emerging and include: Yale 
Open Data Access (YODA) [28] and the Supporting Open Access 
for Researchers (SOAR) initiative [29] , but it is not clear how 
these data repositories will work together without an industry 
backed standard.
Another major concern for data sharing is fairness regarding 
differences in research infrastructure [30]. Countries and 
organizations with well-established research infrastructure are 
better equipped to discover knowledge from shared data sets. 
They will usually have strong analysis pipelines and trained 
biostatisticians and epidemiologists available to perform 
secondary analysis on collected and curated data. This may lead 
to the marginalization of smaller research groups who play an 
important role in collecting and providing data to the research 
community.
Further issues with data sharing include secondary investigators 
using shared data and publishing their results without 
acknowledgment of the initial research team. This issue often 
results in hesitation to share data. A more recent data sharing 
strategy suggests that authorship could be associated with 
a published dataset [31]. This allows the investigators and 
team responsible for collecting and curating a set of clinical 
data to publish it online in a public data repository.  The data 
authors can then be referenced in publications by the original 
investigators themselves or by collaborators and secondary 
investigators. This allows original investigators to get the credit 
they deserve for studies that can be difficult to plan, set up, 
and manage. Many collaborative organizations are forming to 
try to mitigate the problem involving credit for secondary data 
use. The Community Acquired Pneumonia Organization [32] 
was established to facilitate advances in pneumonia research 
through collaboration and data sharing. Other groups include 
the Infectious Diseases Data Observatory [33], the Worldwide 
Anti-malarial Resistance Network [34], the National Surgical 
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Adjuvant Breast and Bowel Project [35]  and many others. 
The benefits of such organizations are substantial and include 
development of better research questions and clear mission 
goals for produced research. One drawback is that while data 
will be consistent within such groups, a common data standard 
is needed to support true multidisciplinary collaboration.
There are several limitations to this study. First, The process 
we describe shifts some technical burden from a secondary 
investigator to the original investigators. There are many 
options available for packaging data objects and investigators 
will need to decide the most efficient means of data stewardship. 
Ultimately, we believe data stewardship and data authorship 
efforts will become formalized in an endorsed standard, making 
the creation process more streamlined and easy.  Until that time, 
investigators should endeavor to follow FAIR principles to the 
best of their ability and make the data they share as accessible as 
possible. Second, the setup process will be specific to the type of 
operating system a secondary investigator is using.  An effective 
container will support the three major operating systems, 
Windows, macOS, and Linux, but this greatly increases the 
work investment for investigators.  Because of the similarities 
between macOS and Linux, supporting Windows and macOS 
is generally sufficient as they comprise 94.05 percent of the 
operating system market share in 2017[36].  Thirdly, it is always 
possible that secondary users will be able to misinterpret share 
data or the results of analysis. We have tried to mitigate this 
as much as possible by providing comments in the analysis 
software code and in the output of results.
Conclusion
We have described a data container capable of effectively 
sharing data along with the software code used to arrive 
at publishable results. In the future graphical plots should 
be added to data objects as they are an important part 
of understanding the results of research. We intend to 
develop software containers that quickly display graphical 
representations from within a data object. Possible means 
include packaging an interactive web environment with the 
data object or using the windowing interface of the host 
machine to display plots from the guest machine. Although 
the primary goal of this project was to outline how data 
can be shared and pre-packaged in an automated analysis 
environment, we believe this can also add to the transparency 
and reproducibility of clinical research findings through 
creation of software containers for results published in peer-
reviewed journals or on clinicaltrials.gov. This increased 
transparency and facilitation of data sharing can enhance high 
quality research and translate into better patient care.
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